The Future of Antibiotics and Resistance
By B. Spellberg, J. Bartlett, D. Gilbert. New England Journal of Medicine, 2013
645 citations recorded by the source corpus.
Antibiotic resistance and the collapse of the antibiotic research-and-development pipeline continue to worsen despite our ongoing efforts. If we're to develop countermeasures that have lasting effects, new ideas that complement traditional approaches are needed.
Subfields: Applied Microbiology and Biotechnology, Clinical Biochemistry, Molecular Medicine
View Paper: https://www.semanticscholar.org/paper/17eb8ae8cfc11dda23fe08018c13d9eeae28e919
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Applied Microbiology and Biotechnology
In Molecular Medicine
Citations in the corpus
- Antibiotic resistance and persistence—Implications for human health and treatment perspectives (2020, neutral): “There are many excellent reviews already published focusing on antibiotic resistance (Turnidge & Christiansen, 2005; Spellberg et al , 2013; Blair et al , 2015; Foster, 2017; Rather et al , 2017; Zaman et al , 2017; Aslam et al , 2018; Jorge et al , 2019; Lopez-Jacome et al , 2019).”
- Development and Use of Personalized Bacteriophage-Based Therapeutic Cocktails To Treat a Patient with a Disseminated Resistant Acinetobacter baumannii Infection (2017, background): “The growing impact of MDR pathogens has increased initiatives to discover infectious disease therapeutics with novel mechanisms of action (7, 8).”